FR266M - - Google Patents

Download PDF

Info

Publication number
FR266M
FR266M FR836478A FR836478A FR266M FR 266 M FR266 M FR 266M FR 836478 A FR836478 A FR 836478A FR 836478 A FR836478 A FR 836478A FR 266 M FR266 M FR 266M
Authority
FR
France
Prior art keywords
cis
urea
trans
compounds
decalyi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR836478A
Other languages
English (en)
French (fr)
Inventor
John Alfred Aeschlimann
Arthur Stempel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US840014A external-priority patent/US2974166A/en
Priority claimed from FR826930A external-priority patent/FR1292947A/fr
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of FR266M publication Critical patent/FR266M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR836478A 1959-05-13 1960-08-23 Expired FR266M (OSRAM)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81283359A 1959-05-13 1959-05-13
US840014A US2974166A (en) 1959-09-15 1959-09-15 Certain 1-arylsulfonyl-3-(cis-2-decalyl)ureas
FR826930A FR1292947A (fr) 1960-05-12 1960-05-12 Procédé pour la préparation de composés polycycliques

Publications (1)

Publication Number Publication Date
FR266M true FR266M (OSRAM) 1961-02-17

Family

ID=39143167

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836478A Expired FR266M (OSRAM) 1959-05-13 1960-08-23

Country Status (2)

Country Link
BE (1) BE590649A (OSRAM)
FR (1) FR266M (OSRAM)

Also Published As

Publication number Publication date
BE590649A (fr) 1960-11-09

Similar Documents

Publication Publication Date Title
EP0506539B1 (fr) Amides alkyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0605622A1 (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
WO1994015955A1 (fr) Derives de thiazolidine, leur preparation et les medicaments les contenant
BE897737A (fr) Procede de resolution d'isomeres optiques, les isomeres ainsi produits et leur application pharmacologique
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
US20030055009A1 (en) Non-peptidic cyclophilin binding compounds and their use
DE68912020T2 (de) N-2,3-Butadienyl-tri-aminoalkanderivate.
FR266M (OSRAM)
BE1001621A3 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments.
CH661661A5 (fr) Agent antineoplasique.
EP0113330B1 (fr) Composés énamides acylés, compositions pharmaceutiques les contenant, utilisation de ces composés et procédé de préparation de ces composés
EP0105821B1 (fr) Nouvelles N-(aminométhyl-5-oxazolin-2-yl-2)N'-phénylurées
US3920829A (en) Inflammation inhibiting bis-carbamate composition
EP0092287B2 (fr) Sels d'acétylcystéine, leur préparation et leur utilisation
EP0015798B1 (fr) Dérivés de thiazole, leur préparation et médicaments les contenant
EP0179076B1 (fr) Derives sulfures de l'hydantoine et compositions pharmaceutiques les contenant
CA2405076A1 (fr) Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
CH624922A5 (en) Process for the preparation of new methylamine derivatives
FR2500454A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
EP0035945B1 (fr) Nouvelles guanidines acylées, urées et urées substituées, leur procédé de fabrication et leur application en tant que médicaments
FR2545489A1 (fr) Nouveaux derives n-acyles du 2-oxo-thiazolidine-4-carboxylate de 4-aminophenyle, leur preparation et leur utilisation comme medicaments
CH615663A5 (OSRAM)
BE884897R (fr) Preparations pharmaceutiques
BE646581A (OSRAM)